Federal contract award
75F40122C00014
FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 812930 — Parking Lots and Garages |
| PSC | X1LZ — LEASE/RENTAL OF PARKING FACILITIES |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $406.1K |
| Current contract value | $406.1K |
| Potential contract value / ceiling | $429.2K |
| Start date | Jan 1, 2022 |
| Current end date | Jul 31, 2026 |
| Potential end date | Jul 31, 2026 |
| Latest award activity | Jul 30, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 30, 2026 | P00009 | $-15.3K | EO 14398 - FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVI |
| Dec 30, 2025 | P00008 | $69.0K | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
| Aug 18, 2025 | P00007 | $0 | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
| Apr 28, 2025 | P00006 | $0 | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
| Dec 9, 2024 | P00005 | $92.1K | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
| Dec 19, 2023 | P00004 | $89.4K | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
| Nov 28, 2022 | P00003 | $86.8K | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
| Nov 18, 2022 | P00002 | $0 | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
| Jun 21, 2022 | P00001 | $0 | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
| Jan 1, 2022 | 0 | $84.2K | FDA'S SENIOR EXECUTIVES ARE REQUIRED TO TRAVEL FROM VARIOUS FDA OFFICES WITHIN THE WASHINGTON, DC METROPOLITAN TO ATTEND MANDATORY EXECUTIVE MEETINGS AND AT TIME ON SHORT NOTICE. TWENTY-FIVE (25) RESERVED PARKING SPACES SHALL BE PROVIDED BY THE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.